[Corrigendum] Enhanced antitumor activity by the combination of dasatinib and combretastatin A‑4 in vitro and in vivo. - Zhang C; Zhou SS; Li XR; Wang BM; Lin NM; Feng LY; Zhang DY; Zhang LH; Wang UB; Pan JP (Oncology reports, 2024)